Plasma lipids and desogestrel and ethinyl estradiol: A meta-analysis

Fertility and Sterility

Volumn 65, Issue 6, 1996, Pages 1100-1109

  Lobo, R A ^a   Skinner, J B ^a   Lippman, J S ^a   Cirillo, S J ^a  

^a Columbia University ^*  (United States)

Author keywords

(HDL C); cholesterol; Desogestrel; ethinyl E2; high density lipoprotein cholesterol; low density lipoprotein cholesterol; triglycerides

Indexed keywords

DESOGESTREL; ETHINYLESTRADIOL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; FEMALE; HEART PROTECTION; HORMONAL REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID BLOOD LEVEL; META ANALYSIS; ORAL CONTRACEPTION; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; STATISTICAL ANALYSIS;

EID: 0029951341     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0015-0282(16)58321-6     Document Type: Article

References (53)

1. Consensus Development Meeting Metabolic aspects of oral contraceptives of relevance for cardiovascular diseases Am J Obstet Gynecol 162 1990 1335 1337
2. M.J. Stampfer W.C. Willett G.A. Colditz F.E. Speizer C.H. Hennekens A prospective study of past use of oral contraceptive agents and risk of cardiovascular diseases N Engl J Med 319 1988 1313 1317
3. H.J. Engel E. Engel P.R. Lichtlen Coronary atherosclerosis and myocardial infarction in young women—role of oral contraceptives Eur Heart J 4 1983 1 6
4. E. Hirvonen J. Idanpaan-Heikkila Cardiovascular death among women under 40 years of age using low-estrogen oral contraceptives and intrauterine devices in Finland from 1975–1984 Am J Obstet Gynecol 163 1990 281 284
5. D.R. Jacobs I.L. Mebane S.I. Bangdiwala M.H. Criqui H.A. Tyroler High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: the follow-up study of the Lipid Research Clinics Prevalence Study Am J Epidemiol 131 1990 32 47
6. D.J. Gordon J.L. Probstfield R.J. Garrison J.D. Neaton W.P. Castelli J.D. Knoke High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies Circulation 79 1989 8 15
7. M.R. Adams T.B. Clarkson D.R. Koritnik H.A. Nash Contraceptive steroids and coronary artery atherosclerosis in cynomolgus macaques Fertil Steril 47 1987 1010 1018
8. K.R. Petersen S.O. Skouby A. Dreisler C. Kuehl B. Svenstrup Comparative trial of the effects on glucose tolerance and lipoprotein metabolism of two new oral contraceptives containing gestoden and desogestrel Acta Obstet Gynecol Scand 67 1988 37 41
9. T. Agoestina U. Sabarudin G. Hoppe A study comparing a gestoden triphasic formulation with a fixed combination OC Adv Contracept 5 1989 71 84
10. S. Bertolini N. Elicio R. Cordera G.L. Gapitanio G. Montagna S. Croce Effects of three low-dose oral contraceptive formulations on lipid metabolism Acta Obstet Gynecol Scand 66 1987 327 332
11. U.J. Gaspard M.A. Romus D. Gillain Comparative study of lipid metabolism and endocrine function in women receiving levonorgestrel-and desogestrel-containing oral contraceptives R.F. Harrison J. Bonnar W. Thompson Fertility and Sterility; the Proceedings of the 11th World Congress on Fertility and Sterility 1984 MTP Press Limited Dublin 605 611
12. J.A. Gevers Leuven M.C. Dersjant-Roorda F.M. Helmerhorst R. de Boer A. Neymeyer-Leloux L. Havekes Estrogenic effect of gestodene- or desogestrel-containing oral contraceptives on lipoprotein metabolism Am J Obstet Gynecol 163 1990 358 362
13. J.A. Gevers Leuven G.J.A. Drijkoningen J. Alers L. Havekes M. Dersjant-Roorda The effect of low dose oral contraceptives on lipoprotein lipid and apolipoprotein levels in smoking and non-smoking women Tgo Tijdschr Ther Geneesmiddel Onderz 13 1988 355 359
14. P.C. Ho W.T. Liu M.S.W. Kwan Serum lipids in Chinese patients using oral contraceptive pills Contraception 41 1990 55 61
15. H.J. Kloosterboer R.G.A. Wayjen A. van den Ende Comparative effects of monophasic desogestrel plus ethinyloestradiol and triphasic levonorgestrel plus ethinyloestradiol on lipid metabolism Contraception 34 1986 135 144
16. H.J. Kloosterboer H. Rekers Effects of three combined oral contraceptive preparations containing desogestrel plus ethinyl estradiol on lipid metabolism in comparison with two levonorgestrel preparations Am J Obstet Gynecol 163 1990 370 373
17. H. Kuhl W. Maerz C. Jung-Hoffmann F. Heidt W. Gross Time-dependent alterations in lipid metabolism during treatment with low-dose oral contraceptives Am J Obstet Gynecol 163 1990 363 369
18. W. Maerz C. Jung-Hoffman F. Heidt W. Gross H. Kuhl Changes in lipid metabolism during 12 months of treatment with two oral contraceptives containing 30 μ g ethinylestradiol and 75 μ g gestodene or 150 μ g desogestrel Contraception 41 1990 245 257
19. F. Pansini C. Ferrari S. Guerra P. Bassi N. Guzzinati G. Cocilovo Advantage of desogestrel-containing pill in oral contraception; influence on blood lipids and LCAT activity Clin Exp Obstet Gynecol 14 1987 136 139
20. G.E. Robinson W. Bounds I.J. Mackie J. Stocks T. Burren S. Machin Changes in metabolism induced by oral contraceptives containing desogestrel and gestodene in older women Contraception 42 1990 263 273
21. G. Samsioe Comparative effects of the oral contraceptive combinations 0.150 mg desogestrel + 0.030 mg ethinyloestradiol and 0.150 mg levonorgestrel + 0.030 mg ethinyloestradiol on lipid and lipoprotein metabolism in healthy female volunteers Contraception 25 1982 487 504
22. O. Ylikorkala T. Kuusi M.J. Tikkanen L. Viinikka Desogestrel- and levonorgestrel-containing oral contraceptives have different effects on urinary excretion of prostacyclin metabolites and serum high density lipoproteins J Clin Endocrinol Metab 65 1987 1238 1242
23. L. Zichella R. Antonini E. Calzolari M. Mancone G. Perrone C. Stefanutti Metabolic evaluation of women using three different oral contraceptives: a comparison A.R. Genazzani A. Volpe F. Facchinetti Gynecological Endocrinology: the Proceedings of the 1st International Congress on Gynecological Endocrinology 1987 The Parthenon Publishing Group Carnforth 399 403
24. I. Rákóczi G. Gerö J. Demeter I. Gáti Comparative metabolic effects of oral contraceptive preparations containing different progestagens. Effects of desogestrel + ethinylestradiol on the haemostatic balance Arnzneim Forsch 35 1985 630 633
25. W. Maerz W. Gross G. Gahn G. Rombert H.D. Taubert D. Kuhl A randomized crossover comparison of two low-dose contraceptives: effects on serum lipids and lipoproteins Am J Obstet Gynecol 153 1985 287 293
26. E.W. Bergink N.E. Borglin P. Klottrup P. Liukko Effects of desogestrel and levonorgestrel in low-dose oestrogen oral contraceptives on serum lipoproteins Contraception 25 1982 477 485
27. E.W. Bergink E.S. Bos H.J. Kloosterboer L. Lund S. Nummi J. van der Vies Comparison of the metabolic effects of desogestrel and of levonorgestrel in low-dose oestrogen oral contraceptives P.A. van Keep H. Kopera Oral Contraceptives and Lipoproteins; Workshop Conference in Hawaii 1983 International Health Foundation Geneva 52 63
28. G. Cullberg G. Samsioe R.F. Andersen P. Bredesgaard N.B. Anderson H. Ernerot Two oral contraceptives, efficacy, serum proteins, and lipid metabolism. A comparative multicentre study on a triphasic and a fixed dose combination Contraception 26 1982 229 243
29. C. Harvengt J.P. Desager U. Gaspar M. Lepot Changes in lipoprotein composition in women receiving two low-dose oral contraceptives containing ethinylestradiol and gonane progestins Contraception 37 1988 565 575
30. R.N.V. Prasad D. Liew S.S. Ratnam Comparative metabolic effects of three types of combined oral contraceptive pills in Chinese women Contraception 39 1989 21 35
31. A. Rojanasakul L. Chailurkit R. Sirimongkolkasem K. Chaturachinda Effects of combined desogestrel-ethinylestradiol treatment on lipid profiles in women with polycystic ovarian disease Fertil Steril 48 1987 581 585
32. K.E. Sapire G.M.B. Berger J.S. Maritz The clinical and biochemical effects of two combination oral contraceptive agents S Afr Med J 79 1991 376 379
33. A. Steinmetz K. Bauer R. Jürgensen H. Kaffarnik Low-dose oral contraceptives lower plasma levels of apolipoprotein E Eur J Obstet Gynecol Reprod Biol 37 1990 155 162
34. N. van der Vange H.J. Kloosterboer A.A. Haspels Effects of seven low dose combined oral contraceptives on high density lipoprotein subfractions Br J Obstet Gynaecol 94 1987 559 567
35. A. Wiseman J. Bowie D. Cogswell J. Dewbury M. Hamilton F. Hutchinson Marvelon; clinical experience in the UK Br J Fam Plann 10 Suppl 1984 38 42
36. J.A. Yabur M. Alvarado V. Brito Clinical evaluation of a new combined oral contraceptive desogestrel-ethinylestradiol Adv Contracept 5 1989 57 70
37. I.F. Godsland D. Crook R. Simpson T. Proudler C. Felton B. Lees The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism N Engl J Med 323 1990 1375 1381
38. C.P. Schijf C.M.G. Thomas P.N.M. Demacker W.H. Doesburg R. Rolland The influence of the triphasic pill and a desogestrel-containing combination pill on some physical, biochemical and hormonal parameters: a preliminary report R.F. Harrison J. Bonnar W. Thompson Fertility and Sterility; the Proceedings of the 11th World Congress on Fertility and Sterility 1984 MTP Press Limited Dublin 585 593
39. E.W. Bergink H.J. Kloosterboer L. Lund S. Nummi Effects of levonorgestrel and desogestrel in low-dose oral contraceptive combinations on serum lipids, apolipoproteins A-I and B and glycosylated proteins Contraception 30 1984 61 72
40. R.B. D’Agostino A. Belanger R.B. D’Agostino Jr. A suggestion for using powerful and informative tests of normality Am Stat 44 1990 316 321
41. K. Fotherby Oral contraceptives, lipids and cardiovascular disease Contraception 31 1985 367 394
42. B. Nilsson B. von Schoultz Binding of levonorgestrel, nor-ethisterone and desogestrel to human sex hormone binding globulin and influence on free testosterone levels Gynecol Obstet Invest 27 1989 151 154
43. I.F. Godsland D. Crook V. Wynn Coronary heart disease risk markers in users of low-dose oral contraceptives J Reprod Med 36 Suppl 1991 226 237
44. S.B. Hully R.H. Rosenman R.D. Bawol R.J. Brand Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart disease N Engl J Med 302 1982 1383 1389
45. N. Crona G. Silfverstolpe G. Samsioe Changes in serum apolipoprotein Al and sex-hormone-binding globulin levels after treatment with two different progestins administered alone and in combination with ethinyl estradiol Contraception 29 1984 261 270
46. K. Fotherby Effect of oral contraceptives on serum apoprotein levels Adv Contracept 1 1985 237 238
47. K. Fotherby Effect of oral contraceptives on serum apoprotein levels Adv Contracept 2 1986 65 69
48. F. Pazzucconi B. Malavasi G. Galli G. Franceschini L. Calabresi C.R. Sirtori Inhibition of antipyrine metabolism by low-dose contraceptives with gestodene and desogestrel Clin Pharmacol Ther 49 1991 278 284
49. I.F. Godsland D. Crook V. Wynn Clinical and metabolic considerations of long-term oral contraceptive use Am J Obstet Gynecol 166 1992 1955 1963
50. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial JAMA 273 1995 199 208
51. T.L. Bush E. Barett-Connor L.D. Cowan M.H. Criqui R.B. Wallace C.M. Suchindran Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study Circulation 75 1987 1102 1109
52. J. De Graaf D.W. Swinkels P.N.M. Demacker A.F.J. De Haan A.F.H. Stalenhoef Differences in the low density lipoprotein subfraction profile between oral contraceptive users and controls J Clin Endocrinol Metab 76 1993 197 202
53. R.A. Lobo L. Speroff International consensus conference on postmenopausal hormone therapy and the cardiovascular system Fertil Steril 61 1994 592 595